Q2 2017 13F Holders as of 6/30/2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
56.2M
-
Number of holders
-
192
-
Total 13F shares, excl. options
-
33.9M
-
Shares change
-
+3.38M
-
Total reported value, excl. options
-
$1.41B
-
Value change
-
+$144M
-
Put/Call ratio
-
1.21
-
Number of buys
-
115
-
Number of sells
-
-58
-
Price
-
$41.44
Significant Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q2 2017
216 filings reported holding RGEN - REPLIGEN CORP - COMMON STOCK as of Q2 2017.
REPLIGEN CORP - COMMON STOCK (RGEN) has 192 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33.9M shares
of 56.2M outstanding shares and own 60.33% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4.83M shares), TimesSquare Capital Management, LLC (2.36M shares), VANGUARD GROUP INC (1.98M shares), OppenheimerFunds, Inc. (1.74M shares), Invesco Ltd. (1.67M shares), FMR LLC (1.33M shares), Conestoga Capital Advisors, LLC (1.29M shares), STATE STREET CORP (1.17M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (1.06M shares), and Ranger Investment Management, L.P. (919K shares).
This table shows the top 192 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.